Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.4018
+0.0205 (5.38%)
At close: May 19, 2025, 4:00 PM
0.4000
-0.0018 (-0.45%)
After-hours: May 19, 2025, 7:20 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $26.93 million as of May 19, 2025. Its market cap has decreased by -86.97% in one year.
Market Cap
26.93M
Enterprise Value
-44.40M
1-Year Change
-86.97%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $26.93M, a decrease of -97.49%. That is a compound annual growth rate of -52.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 26.93M | -61.96% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |